Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. (EKSO) designs and sells powered exoskeletons for medical rehabilitation and industrial applications. Its products — including wearable robotic suits for gait and upper‑limb support and industrial assistive devices — aim to help patients regain mobility and reduce workplace strain. For investors, Ekso is a small, speculative company: with a market capitalisation around $12.8m it may face limited liquidity, wide price swings and heightened sensitivity to funding and order flow. Key drivers include clinical adoption, favourable reimbursement and industrial safety demand; headwinds include competition, regulatory hurdles, manufacturing scale‑up and possible cash‑burn. Public information on revenues, profit and cash runway should be checked before considering exposure. This summary is educational only, not personalised advice. Values can rise or fall and past performance is not a guide to future returns. Ekso may suit investors seeking exposure to assistive robotics with a high risk tolerance and time horizon; those unsure should consult a qualified financial adviser.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Ekso Bionics' stock with a target price of $10, indicating significant growth potential.
Financial Health
Ekso Bionics has steady revenue and cash flow, but its profitability remains a moderate concern.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring EKSO
Wearable Tech IP Wars: What Investors Should Know
Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.
Published: August 21, 2025
Explore BasketImmersive Rehab & VR Therapy
Virtual and augmented reality are transforming healthcare with innovative digital treatments for physical and psychological healing. These carefully selected companies are at the forefront of creating immersive technologies that offer effective alternatives to traditional therapies, poised to benefit from growing clinical acceptance.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Assistive Robotics Growth
Ageing populations and rehabilitation needs may support long‑term demand, though commercial adoption can be slow and outcomes uncertain.
Industrial Support Tools
Exoskeletons for workplaces aim to reduce injury and improve productivity; pilot programmes drive interest but scale and cost remain hurdles.
Small‑Cap Considerations
With a modest market cap, EKSO can be volatile and less liquid — investors should weigh reward potential against higher risk and possible dilution.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
